BMC nephrology
Network meta-analysis of HIF-prolyl hydroxylase inhibitors for anemia in dialysis-dependent and non-dialysis CKD: effects on hemoglobin, iron markers, and adverse clinical outcomes.
Hasti Nasiri, Amirali Mirmazhari, Leila Mirzakhani, Parham Asgarian, Ali Gholibeigi, Tina Ghandali, Maryam Talebi Moghaddam, Mehdi Mohammadi, Mehdi Karimi, Atieh Makhlough
Published: 202510.1186/s12882-025-04561-x
No abstract available for this study.